Brian Sparling

Company: Accent Therapeutics

Job title: Director & Head, Medicinal Chemistry

Seminars:

Boosting Confidence in Early-Stage Drug Candidates Through Orthogonal Readouts & SAR Analysis 4:15 pm

Integrating multiple assay platforms to validate hit specificity for targeting DHX9 and KIF18A Adopting a SAR analysis approach for fine-turning compound structure and improving bioactivity Combining assay expertise with deep cancer biology to succeed in hit binding and minimize off-target effectsRead more

day: Day One